DSM Anti-Infectives sets up facility at Punjab

DSM Anti-Infectives has opened a facility at Toansa in Punjab for the production of Ampicillin. The company has implemented a novel enzymatic process for production of the Active Pharmaceutical Ingredient (API) which will help generate less waste compared to the conventional processes. Since this is an innovative application, the company has branded the Ampicillin API as Puricillin which comes under the umbrella of products Pure Actives. The product is being produced utilizing an eco-friendly enzymatic process using no organic solvents. 

DSM in India is a wholly-owned subsidiary of the parent company based in Netherlands. The new facility will cater to orders of the Asia Pacific region, Middle- East and African countries, in addition to the Indian market. 


Popular posts from this blog

GOP Senator says it's hard to fund $14 billion children's health care program — then advocates for $1 trillion tax cut

Trump wants more mental health care; Alabama says it's trying